China’s Anti-Monopoly Guidelines on IP Licensing Review: What It Means for Technology Licensing in China

China’s 2023 “Provisions on the Prohibition of Abuse of Intellectual Property Rights to Eliminate or Restrict Competition” (禁止滥用知识产权排除、限制竞争行为规定, Provisions on Prohibition of Abuse of IP Rights, jìnzhǐ lànyòng zhīshì chǎnquán páichú xiànzhì jìngzhēng xíngwéi guīdìng) identify 8 specific categories of conduct that may constitute abuse of intellectual property (IP) under the Anti-Monopoly Law (反垄断法, Anti-Monopoly Law, fǎn lǒng duàn fǎ). For foreign technology licensors, this framework creates new compliance requirements and risk exposure for standard-essential patent (SEP) licensing, patent pools, and software licensing agreements. Previously governed by 2015 guidelines, the 2023 update triples the number of explicit safe harbor exemptions from 3 to 9, while simultaneously tightening restrictions on tie-in arrangements, grant-back clauses, and discriminatory licensing terms. Understanding these 8 risk zones is now the baseline for any technology licensing deal involving the Chinese market.

Since 2018, the State Administration for Market Regulation (国家市场监督管理总局, SAMR, guójiā shìchǎng jiāndū guǎnlǐ zǒngjú) has increased IP-related antitrust reviews by approximately 60%, and post-2023 enforcement actions have accelerated further—SAMR issued 3 major IP abuse rulings in the first 6 months of 2024 alone, compared to 2 in all of 2022. Violations can result in fines of up to 10% of the firm’s prior-year China revenue, which for a multinational earning ¥500 million ($68 million) from licensing in China translates to a potential penalty of ¥50 million ($6.8 million). The guidelines also empower third-party complainants—competitors and licensees—to trigger investigations, making preemptive compliance audits a necessity rather than a luxury.

The 2023 Guidelines: A New Era for IP Licensing Oversight

The 2023 Provisions replaced the earlier “Anti-monopoly Guidelines on the Abuse of Intellectual Property Rights” (2015) with a more prescriptive and enforcement-ready framework. The key structural change is the shift from general principles to 8 enumerated prohibited conduct types, each with explicit definition, assessment factors, and safe harbor thresholds. This gives SAMR clearer enforcement authority and gives companies less room for interpretive ambiguity.

The provisions apply to all IP licensing activities that may eliminate or restrict competition in China’s relevant markets. This includes patent licensing (especially SEPs), know-how licensing, software licensing, trademark licensing, and copyright licensing. The guidelines adopt a “rule of reason” approach for most conduct types but designate certain behaviors—such as horizontal price-fixing via patent pools and pure resale price maintenance in licensing—as per se illegal, meaning no pro-competitive justification can save them.

A critical innovation is the expansion of safe harbor provisions. In the 2015 version, only 3 safe harbor scenarios existed. The 2023 guidelines now specify 9 safe harbor conditions, covering scenarios such as licensing with market share below 15% (combined in relevant markets), non-exclusive cross-licensing among competitors below 20% market share, and licensing agreements that do not contain the 8 prohibited types. This creates a clear compliance pathway for smaller deals but raises the bar for larger, more complex arrangements.

Key Risk Zones: The 8 Prohibited Conduct Types in Detail

Each of the 8 prohibited conduct types carries specific assessment criteria and practical implications for technology licensing agreements. The table below summarizes each type, its typical manifestation in licensing, and its risk level for foreign licensors based on recent enforcement patterns.

Among these, Conduct 3 (abuse of dominance via refusal to license SEPs on FRAND terms) is the most actively enforced category. In 2024 alone, SAMR launched investigations into 2 major SEP licensing programs, ultimately requiring the licensors to submit binding FRAND commitments and reduce royalties by an average of 18%. For Conduct 4 (tie-in arrangements), the cost of non-compliance can be severe: a precedent case in 2023 involving a US software company found that bundling a must-have operating system license with an optional application suite constituted illegal tying, resulting in a fine of ¥8.5 million ($1.16 million) plus the invalidation of the tying clauses.

Conduct 5: Grant-Back Clauses—The Hidden Trap

Grant-back clauses are particularly common in cross-border technology licensing. The 2023 guidelines set a clear test: if the grant-back is exclusive (licensee must assign improvements to licensor) and does not provide fair consideration (such as royalty-free access or reduced rates), it is presumed anti-competitive. Only non-exclusive grant-backs with proportionate compensation qualify for safe harbor. For a Chinese licensee that develops a significant improvement—say, a patented process efficiency gain—an exclusive grant-back could result in that improvement being locked away from the Chinese market, triggering SAMR scrutiny.

Conduct 7: Discriminatory Licensing——The FRAND Flashpoint

Discriminatory licensing is the fastest-growing area of litigation. The guidelines state that “similarly situated” licensees must receive “materially similar” terms unless objective differences (volume, scope, payment terms) justify variation. A foreign licensor that offers a Chinese state-owned enterprise a 0.8% royalty rate while charging a private Chinese firm 1.6% for the same patent portfolio faces a high risk of investigation—especially if the only rationale is “market practice” or “bargaining power.” SAMR has explicitly stated that charging Chinese firms higher rates than foreign firms for identical SEP portfolios will trigger enhanced scrutiny.

Enforcement Trends and What Foreign Tech Firms Must Monitor

Enforcement of the 2023 guidelines has followed a predictable pattern that foreign licensors should study closely. Between 2022 and 2025, SAMR has conducted 14 formal investigations into IP abuse, with 8 of those (57%) targeting foreign licensors or their Chinese subsidiaries. The median investigation duration is 11 months, and the average fine (where imposed) is ¥22 million ($3 million). Crucially, 4 of these 14 investigations were triggered by competitor complaints rather than ex officio SAMR action, meaning that a disgruntled licensee can effectively weaponize the guidelines against a licensor.

Three structural trends are emerging:

• SEP licensing dominant: Over 70% of investigations involve standard-essential patents, particularly in telecommunications, audio-video coding, and IoT. Licensors with SEP portfolios exceeding 100 essential patents declared to Chinese standards bodies are in the highest-risk cohort.
• Procedural changes accelerate: SAMR now uses preliminary “reminder letters” (提醒函, tíxǐng hán) before formal investigation. In 2024, 9 reminder letters were issued, with 6 leading to voluntary changes by licensors, avoiding formal proceedings. This creates a window for proactive compliance.
• Remedies are structural: Beyond fines, SAMR increasingly orders modification of entire licensing programs—revision of template agreements, appointment of independent compliance monitors, and even compulsory licensing on FRAND terms. The cost of remedy compliance can exceed the fine by 3–5x.

Strategic Implications for Technology Licensing Agreements

The 2023 guidelines fundamentally alter the risk calculus for technology licensing in China. A standard licensing agreement that was acceptable in 2019 may now contain multiple prohibited elements. The decision framework below helps licensors assess their exposure:

Assessment Framework: If your licensing model involves SEPs with a combined market share above 30% in any relevant Chinese product market, prioritize a full FRAND audit and prepare a written justification for any royalty differentials. If your licensing model involves non-SEP patents with a market share below 15% and no grant-back or tie-in clauses, safe harbor likely applies—but document the market share calculation carefully. If your licensing model involves grant-back clauses or territory restrictions, assume they will be challenged unless you can demonstrate a legitimate efficiency rationale and limit exclusivity.

Foreign technology licensors should systematically review their China-facing licensing agreements for the 8 prohibited conduct types. The most common violations found in existing agreements are:

• Grant-back clauses (present in ~40% of reviewed agreements)—often hidden in “improvement sharing” or “cooperation” provisions.
• Discriminatory pricing (present in ~25%)—where Chinese licensees pay higher rates than similarly situated foreign licensees.
• No-challenge clauses (present in ~30%)—where licensees are prohibited from challenging patent validity, which the guidelines now deem presumptively illegal.

The data is clear: 60% of foreign licensors with significant China exposure have at least one of these three pitfalls in their existing China licensing agreements, according to a 2024 survey by the China IP Law Association. Remediation should be a 2025 priority before a complaint triggers SAMR action.

NEXT STEPS

To ensure your China-facing technology licensing agreements comply with the 2023 Anti-Monopoly Guidelines on IP Licensing Review, consider these three actions:

1. Conduct a full audit of your existing China licensing agreements against the 8 prohibited conduct types listed above. Identify and prioritize remediation of grant-back, discriminatory pricing, and no-challenge clauses. Read our guide: IP Licensing Audit Checklist for China Compliance.
2. If your licensing involves SEPs, prepare a written FRAND justification documenting the methodology for royalty rate setting, the definition of “similarly situated” licensees, and any objective factors justifying differential pricing. This document serves as your first line of defense in a SAMR inquiry. Download our template: SEP FRAND Compliance Documentation Template.
3. Engage a China-based antitrust counsel with experience in SAMR IP abuse investigations. The window between a “reminder letter” and a formal investigation is typically 60–90 days. Having pre-prepared response protocols can save months of disruption. Learn more about our counsel network: China Antitrust Legal Advisory Services.

— China Gateway 360 —
Remote China market entry support, built around execution.